Shmuel Banai

Showing 1-14 of 14 articles

Coronary interventions

Coronary sinus narrowing for the treatment of refractory angina: a multicentre prospective open-label clinical study (the REDUCER-I study)

Verheye S, Agostoni P, Giannini F, Hill J, Jensen C, Lindsay S, Stella P, Redwood S, Banai S, Konigstein M

September 20, 2021 | 10.4244/EIJ-D-20-00873

Coronary interventions

Effects of coronary sinus Reducer implantation on oxygen kinetics in patients with refractory angina

Zivelonghi C, Konigstein M, Azzano A, Agostoni P, Topilski Y, Banai S, Verheye S

April 2, 2021 | 10.4244/EIJ-D-19-00766

Interventions for valvular disease

Impact of right ventricular volumes on the outcomes of TAVR: a volumetric analysis of preprocedural computed tomography

Rozenbaum Z, Maret E, Lax L, Shmilovich H, Finkelstein A, Steinvil A, Halkin A, Banai S, Cohen D, Topilski Y, Berliner S, Fleischmann D, Aviram G

June 12, 2020 | 10.4244/EIJ-D-19-00651

Coronary interventions

Technical aspects in coronary sinus Reducer implantation

Giannini F, Tzanis G, Ponticelli F, Baldetti L, Demir O, Mitomo S, Gallone G, Banai S, Colombo A

February 20, 2020 | 10.4244/EIJ-D-18-01180

Coronary interventions

Coronary Sinus Reducer implantation improves symptoms, ischaemia and physical capacity in patients with refractory angina unsuitable for myocardial revascularisation: a single-centre experience

Konigstein M, Bazan S, Revivo M, Banai S

July 20, 2018 | 10.4244/EIJ-D-18-00102

Stents and scaffolds

A prospective randomised trial comparing the novel ridaforolimus-eluting BioNIR stent to the zotarolimus-eluting Resolute stent: six-month angiographic and one-year clinical results of the NIREUS trial

Paradies V, Ben-Yehuda O, Jonas M, Banai S, Iñiguez A, Perlman G, Kandzari D, Stone G, Smits P

May 20, 2018 | 10.4244/EIJ-D-17-00890

Coronary sinus reducer non-responders: insights and perspectives

Baldetti L, Colombo A, Banai S, Latib A, Esposito A, Palmisano A, Giannini F

February 20, 2018 | 10.4244/EIJ-D-17-00626

Coronary interventions

Israel: coronary and structural heart interventions from 2010 to 2015

Finkelstein A, Minha S, Kornowski R, Danenberg H, Banai S, Lotan H, Segev A, Barbash I

May 15, 2017 | 10.4244/EIJ-D-16-00835

Interventions for valvular disease

Transcatheter mitral valve implantation: Tiara

Cheung A, Banai S

September 18, 2016 | 10.4244/EIJV12SYA18

Interventions for valvular disease

Transapical mitral valve implantation after unclipping of a MitraClip: a glimpse into the future and treatment considerations in mitral regurgitation

Dvir D, Cheung A, Boone R, Leipsic J, Blanke P, Perlman G, Moss R, Toma M, Stub D, Banai S, Webb J

June 10, 2016 | 10.4244/EIJV12I2A38

Interventions for valvular disease

The Tiara transcatheter mitral valve implantation system

Verheye S, Cheung A, Leon M, Banai S

September 17, 2015 | 10.4244/EIJV11SWA20

Transcatheter mitral valve implantation with Tiara bioprosthesis

Cheung A, Stub D, Moss R, Boone R, Leipsic J, Verheye S, Banai S, Webb J

September 27, 2014 | 10.4244/EIJV10SUA17

Transcatheter treatment for refractory angina with the coronary sinus Reducer

Konigstein M, Meyten N, Verheye S, Schwartz M, Banai S

February 20, 2014 | 10.4244/EIJV9I10A196

Anomalous origin of the left anterior descending and circumflex coronary arteries from two separate ostia in the right aortic sinus of Valsalva

Abramowitz Y, Aviram G, Finkelstein A, Banai S

April 20, 2011

Latest news

NEW ISSUE

State of the Art on ViV-TAVI; Transseptal Punctures; Endovascular Closure and TF-TAVI; Percutaneous PVL Closure: Long-Term Outcomes; and more

October 20, 2021

STATE OF THE ART

Valve-in-valve TAVI: a practical overview

Giuseppe Tarantini et al.

October 20, 2021

AHEAD OF PRINT

TAVI in younger (<70 years old) patients: the AMTRAC registry

Guy Witberg et al.

October 22, 2021

AHEAD OF PRINT

Impact of LVOT calcification in transfemoral TAVI patients

L. Waldschmidt et al.

Impact of preprocedural biological markers on 10-year mortality in the SYNTAXES trial

Hironori Hara et al.

October 22, 2021

AHEAD OF PRINT

Serum caffeine causes adenosine-induced FFR overestimation

Hideaki Tanaka et al.